Press Release

Eckert & Ziegler Lowers 2022 Profit Guidance to 27 mm EUR

Insider information pursuant to Article 17 MAR


Berlin, 5 July 2022. Due to slow consultation progress and a general worsening of the international business climate the Management Board of Eckert & Ziegler has concluded that the probability of an extraordinary profit from a sale or readjustments of assets, still within calendar year 2022 and in an amount of 14.3 mm EUR, has decreased to less than 50%. On the other hand, a stronger than expected order intake and solid half-year results will raise the 2022 net profit in the recurring business from 24 to 27 mm EUR and hence by 17% compared to 2021. The board therefore in sum revises its 2022 net profit guidance from 38.3 to 27 mm EUR.

The sales forecast for the financial year 2022 published on March 24, 2022 remains unchanged. Here the Executive Board expects an increase to around EUR 200 million. Detailed half year results for 2022 will be published on 11 August 2022.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 


05-Jul-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1391015


 
End of Announcement DGAP News Service

 

show this